Emcure Pharmaceuticals Ltd vs Natural Capsules Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 14, 2026

Key Highlights

The Latest Trading Price of Emcure Pharmaceuticals Ltd is ₹ 1673 as of 14 May 15:30 . The P/E Ratio of Emcure Pharmaceuticals Ltd changed from 29.8 on March 2025 to 29.8 on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of Natural Capsules Ltd changed from 9.7 on March 2021 to 307 on March 2025 . This represents a CAGR of 99.56% over 5 years The Market Cap of Emcure Pharmaceuticals Ltd changed from ₹ 20327 crore on March 2025 to ₹ 20327 crore on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of Natural Capsules Ltd changed from ₹ 67.03 crore on March 2021 to ₹ 190.48 crore on March 2025 . This represents a CAGR of 23.23% over 5 years The revenue of Emcure Pharmaceuticals Ltd for the Mar '26 is ₹ 2484 crore as compare to the Dec '25 revenue of ₹ 2365 crore. This represent the growth of 5.02% The revenue of Natural Capsules Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 38.19 crore. This represent the decline of -100% The ebitda of Emcure Pharmaceuticals Ltd for the Mar '26 is ₹ 493.84 crore as compare to the Dec '25 ebitda of ₹ 456.45 crore. This represent the growth of 8.19% The ebitda of Natural Capsules Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ -1.88 crore. This represent the decline of -100% The net profit of Emcure Pharmaceuticals Ltd changed from ₹ 152.59 crore to ₹ 243.74 crore over 8 quarters. This represents a CAGR of 26.39% The net profit of Natural Capsules Ltd changed from ₹ 0.6 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The Dividend Payout of Emcure Pharmaceuticals Ltd changed from 4.3 % on March 2021 to 17.92 % on March 2025 . This represents a CAGR of 33.04% over 5 yearsThe Dividend Payout of Natural Capsules Ltd changed from 8.96 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 years .

About Emcure Pharmaceuticals Ltd

Emcure Pharmaceuticals Limited was originally incorporated as Emcure Pharmaceuticals Private Limited', as a Private Company, pursuant to a Certificate of Incorporation dated April 16, 1981 issued by Registrar of Companies, Maharashtra at Bombay.
Subsequently, Company was converted into a Public Company and the name of Company was changed to Emcure Pharmaceuticals Limited', through a fresh Certificate of Incorporation issued by the RoC, Maharashtra in Pune on September 18, 2001. Emcure Pharmaceuticals an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
In India, they are present across acute and chronic therapeutic areas, and their key therapeutic areas include gynecology, cardiovascular, vitamins, minerals and nutrients, human immunodeficiency virus antivirals, blood-related and oncology/anti-neoplastics.

About Natural Capsules Ltd

Natural Capsules Limited was incorporated as Public Limited Company established in 1993 at Bangalore.
The Company is one of the leading manufacturers of hard capsule shells in India.
The Company introduced vegetarian capsules to Indian market and is the second-largest manufacturer of gelatin capsules in the country. Company expanded its operations to Puducherry in 2003, further solidifying its position as a trusted brand in the industry.
By venturing into API manufacturing under its subsidiary, Natural Biogenex Private Limited, Company presently operates two distinct business verticals-Capsules and APIs.
The company is a well-equipped modern manufacturing plant to manufacture Hard Gelatin Capsule shells, Hard Cellulose Capsule shells and Pharmaceutical Dosage Forms in Capsule Dosage Form.

FAQs for the comparison of Emcure Pharmaceuticals Ltd and Natural Capsules Ltd

Which company has a larger market capitalization, Emcure Pharmaceuticals Ltd or Natural Capsules Ltd?

Market cap of Emcure Pharmaceuticals Ltd is 31,725 Cr while Market cap of Natural Capsules Ltd is 159 Cr

What are the key factors driving the stock performance of Emcure Pharmaceuticals Ltd and Natural Capsules Ltd?

The stock performance of Emcure Pharmaceuticals Ltd and Natural Capsules Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Emcure Pharmaceuticals Ltd and Natural Capsules Ltd?

As of May 14, 2026, the Emcure Pharmaceuticals Ltd stock price is INR ₹1673.4. On the other hand, Natural Capsules Ltd stock price is INR ₹153.45.

How do dividend payouts of Emcure Pharmaceuticals Ltd and Natural Capsules Ltd compare?

To compare the dividend payouts of Emcure Pharmaceuticals Ltd and Natural Capsules Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.